Although conventionally known as the IGF regulatory protein, IGFBP was recently demonstrated to have pro-tumorigenic activity that is independent of IGF signaling in glioma cells: IGFBP2 contributes to cancer progression by enhancing MMP2 (matrix metalloprotease 2) gene transcription and, in turn, tumor-cell invasion17. Here, MMP2 is linked to neoplasm.